Insider Trading › EXEL › Insiders
EXELIXIS, INC.
EXEL·Nasdaq·
United States·Insider activity
United States·Insider activity$58.33
-0.52 (-0.88%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
EXEL
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
EXELS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, EXEL insiders filed 0 purchases ($0) and 10 sales ($11.1M) on the open market, by 9 insiders. Newest filing Aug 12, 2026 (1 month ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by EXEL insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$11.1MSales · 180 days
2,286Open-market transactions on record
9Insiders filing · 180 days
Purchases (code P) and sales (code S) of EXEL common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
2,286 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Beckerle Mary CDirector · Director | Sale | −9,812 | $53.66 | $527K | 16.1Kdirect | Aug 10, 2026 | Aug 12, 2026 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −3,925 | $50.55 | $198K | 284.4Kdirect | Jun 1, 2026 | Jun 3, 2026 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −9,812 | $50.14 | $492K | 16.1Kdirect | Jun 1, 2026 | Jun 3, 2026 | Form 4 ↗ |
| Aftab DanaEVP, Research and Development | Sale | −43.5K | $50.35 | $2.2M | 594.7Kdirect | May 26, 2026 | May 28, 2026 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −32.1K | $49.81 | $1.6M | 357.6Kdirect | May 20, 2026 | May 22, 2026 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −34.9K | $50.00 | $1.7M | 952.3Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Hefti BrendaSVP and General Counsel | Sale | −6,625 | $50.21 | $333K | 106.8Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Beckerle Mary CDirector | Sale | −7,712 | $48.45 | $374K | 17.5Kdirect | May 7, 2026 | May 8, 2026 | Form 4 ↗ |
| Freire Maria CDirector | Sale | −20.6K | $46.00 | $949K | 100.8Kdirect | May 7, 2026 | May 8, 2026 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −60.0K | $45.71 | $2.7M | 118.8Kdirect | May 7, 2026 | May 8, 2026 | Form 4 ↗ |
| Aftab DanaEVP, Research and Development | Sale | −47.9K | $44.50 | $2.1M | 616.1Kdirect | Feb 24, 2026 | Feb 26, 2026 | Form 4 ↗ |
| Aftab DanaEVP, Research and Development | Sale | −29.9K | $44.35 | $1.3M | 664.0Kdirect | Feb 19, 2026 | Feb 23, 2026 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −99.6K | $44.01 | $4.4M | 279.9Kdirect | Feb 18, 2026 | Feb 20, 2026 | Form 4 ↗ |
| Smith JulieDirector | Sale | −20.0K | $44.30 | $887K | 20.6Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Smith JulieDirector | Sale | −44.1K | $44.50 | $2.0M | 20.6Kdirect | Feb 18, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Hefti BrendaSVP and General Counsel | Sale | −18.7K | $44.01 | $822K | 96.5Kdirect | Feb 18, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Smith JulieDirector | Sale | −42.4K | $43.33 | $1.8M | 20.6Kdirect | Feb 17, 2026 | Feb 19, 2026 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −30.6K | $43.67 | $1.3M | 976.1Kdirect | Feb 17, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −64.8K | $43.50 | $2.8M | 381.9Kdirect | Feb 17, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −3,036 | $43.84 | $133K | 446.7Kdirect | Feb 17, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −34.3K | $43.00 | $1.5M | 1.0Mdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −3,856 | $43.79 | $169K | 17.5Kdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Oliver BobDirector | Sale | −21.2K | $43.90 | $929K | 21.1Kdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Oliver BobDirector | Sale | −9,088 | $43.61 | $396K | 42.3Kdirect | Feb 13, 2026 | Feb 18, 2026 | Form 4 ↗ |
| Caligan Partners LPDirector | Purchase | +27.5K | $43.12 | $1.2M | 1.6Mindirect | Nov 25, 2025 | Nov 26, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −28.0K | $42.58 | $1.2M | 374.0Kdirect | Nov 21, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.6K | $41.77 | $445K | 0indirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −23.5K | $41.93 | $987K | 0indirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $42.11 | $421K | 402.1Kdirect | Nov 20, 2025 | Nov 24, 2025 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −100.0K | $43.55 | $4.4M | 1.2Mdirect | Nov 12, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Aftab DanaEVP, Research and Development | Sale | −48.4K | $42.50 | $2.1M | 664.8Kdirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Beckerle Mary CDirector | Sale | −18.8K | $41.90 | $789K | 21.4Kdirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| Beckerle Mary CDirector | Sale | −5,784 | $42.03 | $243K | 40.2Kdirect | Nov 11, 2025 | Nov 13, 2025 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −7,535 | $43.09 | $325K | 358.9Kdirect | Jun 3, 2025 | Jun 4, 2025 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −4 | $43.67 | $175 | 21.4Kdirect | Jun 2, 2025 | Jun 4, 2025 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −18.8K | $42.74 | $805K | 21.4Kdirect | Jun 2, 2025 | Jun 4, 2025 | Form 4 ↗ |
| Heyman Tomas J.Director | Sale | −4,544 | $44.29 | $201K | 32.5Kdirect | May 21, 2025 | May 22, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −34.4K | $44.06 | $1.5M | 412.1Kdirect | May 20, 2025 | May 22, 2025 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −20.6K | $45.99 | $949K | 169.0Kdirect | May 16, 2025 | May 16, 2025 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −100.0K | $46.00 | $4.6M | 967.8Kdirect | May 16, 2025 | May 16, 2025 | Form 4 ↗ |
| Peterson Amy C.EVP Prod Dev & Med Aff & CMO | Sale | −72.8K | $45.47 | $3.3M | 465.4Kdirect | May 16, 2025 | May 16, 2025 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −15.9K | $44.35 | $704K | 1.3Mdirect | May 15, 2025 | May 16, 2025 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −20.6K | $44.35 | $915K | 1.3Mdirect | May 15, 2025 | May 16, 2025 | Form 4 ↗ |
| Hessekiel JeffreyEVP & General Counsel | Sale | −25.0K | $46.18 | $1.2M | 693.4Kdirect | May 15, 2025 | May 16, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −116.4K | $48.05 | $5.6M | 446.5Kdirect | May 15, 2025 | May 16, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $46.95 | $470K | 446.5Kdirect | May 15, 2025 | May 16, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $42.68 | $427K | 491.2Kdirect | May 14, 2025 | May 16, 2025 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −1,508 | $39.00 | $59K | 693.2Kdirect | May 1, 2025 | May 5, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $38.80 | $388K | 341.0Kdirect | Mar 3, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Smith JulieDirector | Sale | −19.3K | $37.62 | $726K | 10.8Kdirect | Feb 28, 2025 | Feb 28, 2025 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −8,768 | $37.80 | $331K | 356.6Kdirect | Feb 28, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Smith JulieDirector | Sale | −54.5K | $38.13 | $2.1M | 10.8Kdirect | Feb 27, 2025 | Feb 28, 2025 | Form 4 ↗ |
| Oliver BobDirector | Sale | −18.6K | $37.25 | $695K | 33.5Kdirect | Feb 25, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −52.6K | $36.98 | $1.9M | 303.3Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −27.0K | $36.75 | $992K | 511.9Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −29.3K | $36.14 | $1.1M | 779.6Kdirect | Feb 24, 2025 | Feb 26, 2025 | Form 4 ↗ |
| Beckerle Mary CDirector | Sale | −3,856 | $34.90 | $135K | 30.4Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Beckerle Mary CDirector | Sale | −8,354 | $34.87 | $291K | 34.3Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −15.9K | $34.74 | $551K | 169.0Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Freire Maria CDirector | Sale | −44.1K | $34.94 | $1.5M | 91.0Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −3,856 | $35.04 | $135K | 30.4Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Eckhardt Sue GailDirector | Sale | −7,712 | $35.01 | $270K | 34.3Kdirect | Feb 14, 2025 | Feb 19, 2025 | Form 4 ↗ |
| Hessekiel JeffreyEVP & General Counsel | Sale | −60.0K | $36.67 | $2.2M | 486.1Kdirect | Nov 29, 2024 | Dec 2, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $35.27 | $353K | 278.7Kdirect | Nov 22, 2024 | Nov 26, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −19.4K | $34.41 | $667K | 288.7Kdirect | Nov 18, 2024 | Nov 19, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −22.2K | $34.31 | $762K | 308.0Kdirect | Nov 18, 2024 | Nov 19, 2024 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −97.0K | $35.00 | $3.4M | 498.9Kdirect | Nov 5, 2024 | Nov 7, 2024 | Form 4 ↗ |
| Hessekiel JeffreyEVP & General Counsel | Sale | −50.0K | $34.13 | $1.7M | 530.3Kdirect | Nov 1, 2024 | Nov 5, 2024 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −30.0K | $34.00 | $1.0M | 169.0Kdirect | Nov 1, 2024 | Nov 5, 2024 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −1,162 | $31.40 | $36K | 498.9Kdirect | Oct 30, 2024 | Nov 1, 2024 | Form 4 ↗ |
| Hessekiel JeffreyEVP & General Counsel | Sale | −25.0K | $28.39 | $710K | 580.3Kdirect | Oct 28, 2024 | Oct 30, 2024 | Form 4 ↗ |
| Hessekiel JeffreyEVP & General Counsel | Sale | −25.0K | $26.38 | $660K | 605.3Kdirect | Sep 23, 2024 | Sep 25, 2024 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −20.0K | $25.79 | $516K | 630.3Kdirect | Aug 26, 2024 | Aug 28, 2024 | Form 4 ↗ |
| Freire Maria CDirector | Sale | −8,250 | $26.56 | $219K | 91.0Kdirect | Aug 14, 2024 | Aug 16, 2024 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −20.9K | $27.06 | $565K | 500.1Kdirect | Aug 12, 2024 | Aug 14, 2024 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −125.0K | $27.19 | $3.4M | 721.7Kdirect | Aug 9, 2024 | Aug 9, 2024 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −33.7K | $26.89 | $907K | 199.0Kdirect | Aug 8, 2024 | Aug 12, 2024 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −95.0K | $25.00 | $2.4M | 521.0Kdirect | Aug 7, 2024 | Aug 9, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −14.0K | $25.50 | $357K | 341.0Kdirect | Aug 7, 2024 | Aug 9, 2024 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −80.0K | $25.97 | $2.1M | 630.3Kdirect | Aug 7, 2024 | Aug 9, 2024 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −8,287 | $22.00 | $182K | 349.5Kdirect | Jun 4, 2024 | Jun 6, 2024 | Form 4 ↗ |
| JOHNSON DAVID EDWARDDirector | Purchase | +225.0K | $20.76 | $4.7M | 1.5Mindirect | May 30, 2024 | May 30, 2024 | Form 4 ↗ |
| JOHNSON DAVID EDWARDDirector | Purchase | +200.0K | $20.32 | $4.1M | 1.3Mindirect | May 28, 2024 | May 30, 2024 | Form 4 ↗ |
| Smith JulieDirector | Sale | −27.3K | $21.12 | $576K | 5,445direct | May 21, 2024 | May 23, 2024 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −11.7K | $20.96 | $245K | 213.9Kdirect | May 21, 2024 | May 22, 2024 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −11.4K | $21.00 | $240K | 1.3Mdirect | May 20, 2024 | May 22, 2024 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −10.9K | $21.37 | $233K | 338.9Kdirect | May 13, 2024 | May 15, 2024 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −19.2K | $24.01 | $461K | 35.7Kdirect | Mar 21, 2024 | Mar 25, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −47.0K | $21.45 | $1.0M | 384.9Kdirect | Feb 23, 2024 | Feb 27, 2024 | Form 4 ↗ |
| Caligan Partners LPDirector | Purchase | +190.0K | $20.70 | $3.9M | 1.1Mindirect | Feb 21, 2024 | Feb 22, 2024 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −50.0K | $23.35 | $1.2M | 307.7Kdirect | Dec 14, 2023 | Dec 14, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −25.0K | $23.01 | $575K | 533.3Kdirect | Dec 13, 2023 | Dec 14, 2023 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −14.1K | $22.50 | $318K | 307.7Kdirect | Dec 12, 2023 | Dec 14, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −25.0K | $22.06 | $552K | 558.3Kdirect | Dec 4, 2023 | Dec 4, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −25.0K | $22.01 | $550K | 583.3Kdirect | Nov 30, 2023 | Dec 4, 2023 | Form 4 ↗ |
| Caligan Partners LPDirector | Purchase | +120.4K | $21.61 | $2.6M | 910.7Kindirect | Nov 27, 2023 | Nov 29, 2023 | Form 4 ↗ |
| Caligan Partners LPDirector | Sale | −120.4K | $21.61 | $2.6M | 790.3Kindirect | Nov 27, 2023 | Nov 29, 2023 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −4,600 | $22.47 | $103K | 399.9Kdirect | Aug 30, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −60.0K | $20.68 | $1.2M | 571.6Kdirect | Aug 4, 2023 | Aug 7, 2023 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −60.0K | $20.51 | $1.2M | 571.6Kdirect | Aug 3, 2023 | Aug 7, 2023 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −30.6K | $20.67 | $632K | 285.5Kdirect | Aug 3, 2023 | Aug 7, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −55.7K | $19.63 | $1.1M | 572.0Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −38.9K | $20.01 | $779K | 582.4Kdirect | Apr 5, 2023 | Apr 5, 2023 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −15.3K | $16.61 | $254K | 317.5Kdirect | Mar 10, 2023 | Mar 14, 2023 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −77.9K | $17.13 | $1.3M | 527.7Kdirect | Mar 1, 2023 | Mar 3, 2023 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −82.5K | $17.50 | $1.4M | 351.5Kdirect | Feb 28, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Aftab DanaCSO/EVP Disc & Trans Research | Sale | −10 | $17.50 | $175 | 351.5Kdirect | Feb 27, 2023 | Mar 1, 2023 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −40.0K | $17.49 | $700K | 31.4Kdirect | Feb 21, 2023 | Feb 23, 2023 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −40.0K | $17.78 | $711K | 18.7Kdirect | Feb 9, 2023 | Feb 10, 2023 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −25.0K | $17.37 | $434K | 254.4Kdirect | Feb 6, 2023 | Feb 8, 2023 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −20.0K | $15.88 | $318K | 411.0Kdirect | Dec 15, 2022 | Dec 16, 2022 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −40.0K | $16.68 | $667K | 193.2Kdirect | Nov 29, 2022 | Dec 1, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −40.0K | $17.94 | $718K | 261.6Kdirect | Sep 12, 2022 | Sep 14, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −18.8K | $18.21 | $343K | 239.8Kdirect | May 27, 2022 | Jun 1, 2022 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −18.0K | $20.07 | $361K | 586.8Kdirect | May 16, 2022 | Nov 17, 2022 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −40.0K | $19.65 | $786K | 424.4Kdirect | May 12, 2022 | May 13, 2022 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −6,696 | $23.00 | $154K | 273.2Kdirect | Apr 4, 2022 | Apr 6, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $23.00 | $230K | 269.2Kdirect | Apr 1, 2022 | Apr 4, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −10.0K | $22.43 | $224K | 269.2Kdirect | Mar 31, 2022 | Apr 4, 2022 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −13.3K | $22.00 | $292K | 605.2Kdirect | Mar 29, 2022 | Mar 30, 2022 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −4,717 | $22.00 | $104K | 618.5Kdirect | Mar 28, 2022 | Mar 30, 2022 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −21.3K | $21.00 | $447K | 31.4Kdirect | Mar 1, 2022 | Mar 3, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −31.2K | $19.53 | $610K | 198.5Kdirect | Feb 25, 2022 | Feb 28, 2022 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −18.0K | $20.00 | $360K | 555.4Kdirect | Feb 24, 2022 | Feb 28, 2022 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −84.5K | $19.56 | $1.7M | 1.2Mdirect | Feb 22, 2022 | Feb 24, 2022 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −20.0K | $19.49 | $390K | 8,521direct | Feb 22, 2022 | Feb 24, 2022 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −60.0K | $17.91 | $1.1M | 245.2Kdirect | Feb 3, 2022 | Feb 4, 2022 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −47.5K | $17.44 | $828K | 363.2Kdirect | Dec 15, 2021 | Dec 17, 2021 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −17.2K | $17.25 | $297K | 237.8Kdirect | Nov 24, 2021 | Nov 26, 2021 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −20.0K | $17.62 | $352K | 8,521direct | Nov 19, 2021 | Nov 23, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −47.5K | $18.09 | $859K | 411.2Kdirect | Nov 15, 2021 | Nov 17, 2021 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −5,117 | $22.03 | $113K | 632.8Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −47.5K | $21.92 | $1.0M | 411.2Kdirect | Oct 15, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −12.9K | $22.02 | $284K | 637.9Kdirect | Oct 15, 2021 | Oct 15, 2021 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −25.0K | $20.36 | $509K | 281.0Kdirect | Sep 16, 2021 | Sep 17, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −47.5K | $20.46 | $972K | 389.5Kdirect | Sep 15, 2021 | Sep 17, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −55.0K | $18.44 | $1.0M | 389.5Kdirect | Aug 16, 2021 | Aug 18, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −60.0K | $17.47 | $1.0M | 389.5Kdirect | Jul 15, 2021 | Jul 16, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −60.0K | $22.18 | $1.3M | 389.5Kdirect | Jun 17, 2021 | Jun 22, 2021 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −14.6K | $24.73 | $361K | 281.0Kdirect | May 18, 2021 | May 18, 2021 | Form 4 ↗ |
| Hessekiel JeffreyEVP, General Counsel & Sec | Sale | −18.0K | $25.39 | $457K | 604.8Kdirect | May 17, 2021 | Nov 17, 2022 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −40.0K | $25.04 | $1.0M | 66.1Kdirect | May 14, 2021 | May 17, 2021 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −40.8K | $24.97 | $1.0M | 157.2Kdirect | May 14, 2021 | May 17, 2021 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −100.0K | $25.38 | $2.5M | 614.1Kdirect | May 13, 2021 | May 14, 2021 | Form 4 ↗ |
| Freire Maria CDirector | Sale | −8,275 | $25.01 | $207K | 31.8Kdirect | May 11, 2021 | May 17, 2021 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −5,473 | $25.01 | $137K | 1.3Mdirect | May 11, 2021 | May 13, 2021 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −5,075 | $25.00 | $127K | 1.3Mdirect | May 11, 2021 | May 13, 2021 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −10.2K | $24.95 | $255K | 1.2Mdirect | May 11, 2021 | May 13, 2021 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $25.00 | $1.3M | 613.5Kdirect | Apr 26, 2021 | Apr 28, 2021 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −7,665 | $25.03 | $192K | 297.4Kdirect | Apr 26, 2021 | Apr 28, 2021 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −18.0K | $25.03 | $451K | 628.2Kdirect | Apr 26, 2021 | Apr 28, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −60.0K | $22.96 | $1.4M | 389.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $23.00 | $1.1M | 613.5Kdirect | Apr 1, 2021 | Apr 2, 2021 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −6,220 | $22.64 | $141K | 231.6Kdirect | Mar 29, 2021 | Mar 31, 2021 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −40.0K | $23.60 | $944K | 12.7Kdirect | Mar 15, 2021 | Mar 17, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −65.0K | $22.11 | $1.4M | 340.1Kdirect | Mar 1, 2021 | Mar 3, 2021 | Form 4 ↗ |
| COHEN CHARLESDirector | Sale | −40.0K | $22.69 | $908K | 181.4Kdirect | Feb 24, 2021 | Feb 26, 2021 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −800 | $22.34 | $18K | 424.4Kdirect | Feb 23, 2021 | Feb 24, 2021 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −39.2K | $21.92 | $859K | 425.2Kdirect | Feb 23, 2021 | Feb 24, 2021 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −24.1K | $22.29 | $537K | 66.1Kdirect | Feb 22, 2021 | Feb 24, 2021 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $22.35 | $1.1M | 540.6Kdirect | Feb 18, 2021 | Feb 19, 2021 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $22.50 | $1.1M | 540.6Kdirect | Feb 17, 2021 | Feb 19, 2021 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −50.0K | $21.90 | $1.1M | 424.4Kdirect | Feb 16, 2021 | Feb 24, 2021 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −20.0K | $21.96 | $439K | 8,521direct | Feb 16, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −45.0K | $21.57 | $971K | 246.9Kdirect | Feb 12, 2021 | Feb 17, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −65.0K | $22.08 | $1.4M | 283.1Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −30.0K | $25.00 | $750K | 245.6Kdirect | Jan 12, 2021 | Jan 14, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −65.0K | $20.32 | $1.3M | 283.1Kdirect | Jan 4, 2021 | Jan 6, 2021 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −65.0K | $20.01 | $1.3M | 283.1Kdirect | Dec 18, 2020 | Dec 22, 2020 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −40.0K | $18.50 | $740K | 90.2Kdirect | Nov 24, 2020 | Nov 25, 2020 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −34.0K | $20.61 | $701K | 197.8Kdirect | Nov 10, 2020 | Nov 13, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −39.7K | $21.95 | $872K | 343.0Kdirect | Oct 21, 2020 | Oct 23, 2020 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −10.0K | $25.00 | $250K | 127.9Kdirect | Oct 8, 2020 | Oct 9, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −10.3K | $26.14 | $268K | 343.0Kdirect | Sep 22, 2020 | Sep 24, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −4,680 | $26.09 | $122K | 115.6Kdirect | Sep 21, 2020 | Sep 23, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −20.0K | $26.11 | $522K | 343.0Kdirect | Sep 16, 2020 | Sep 16, 2020 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −20.0K | $25.00 | $500K | 127.9Kdirect | Sep 15, 2020 | Sep 15, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −3,151 | $25.36 | $80K | 112.2Kdirect | Jul 20, 2020 | Jul 22, 2020 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −26.0K | $22.56 | $587K | 126.5Kdirect | Jun 8, 2020 | Jun 10, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −100.0K | $22.96 | $2.3M | 326.0Kdirect | Jun 4, 2020 | Jun 5, 2020 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −36.1K | $24.42 | $882K | 12.7Kdirect | May 22, 2020 | May 22, 2020 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −40.0K | $24.64 | $986K | 90.2Kdirect | May 21, 2020 | May 22, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −3,151 | $24.99 | $79K | 115.3Kdirect | May 20, 2020 | May 22, 2020 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −30.0K | $26.26 | $788K | 368.3Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −75.0K | $25.96 | $1.9M | 714.7Kdirect | May 18, 2020 | May 20, 2020 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −15.0K | $25.26 | $379K | 368.3Kdirect | May 14, 2020 | May 15, 2020 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −30.0K | $26.30 | $789K | 82.5Kdirect | May 11, 2020 | May 13, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −38.0K | $27.09 | $1.0M | 239.2Kdirect | May 11, 2020 | May 11, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −25.0K | $26.04 | $651K | 239.2Kdirect | May 8, 2020 | May 11, 2020 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −78.6K | $25.81 | $2.0M | 120.7Kdirect | May 8, 2020 | May 8, 2020 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −45.0K | $25.84 | $1.2M | 1.1Mdirect | May 8, 2020 | May 8, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −21.4K | $25.87 | $553K | 118.5Kdirect | May 8, 2020 | May 8, 2020 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −30.0K | $25.61 | $768K | 239.2Kdirect | May 7, 2020 | May 11, 2020 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −21.4K | $25.80 | $553K | 120.7Kdirect | May 7, 2020 | May 8, 2020 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −31.5K | $25.02 | $789K | 8,521direct | May 7, 2020 | May 8, 2020 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −30.0K | $25.61 | $768K | 112.8Kdirect | May 7, 2020 | May 8, 2020 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −50.0K | $25.54 | $1.3M | 126.5Kdirect | May 7, 2020 | May 8, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −15.0K | $26.24 | $394K | 738.0Kdirect | Apr 24, 2020 | Apr 24, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −100.0K | $26.00 | $2.6M | 325.1Kdirect | Apr 23, 2020 | Apr 24, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −55.7K | $26.23 | $1.5M | 753.0Kdirect | Apr 23, 2020 | Apr 24, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −44.3K | $25.68 | $1.1M | 808.7Kdirect | Apr 23, 2020 | Apr 24, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −5,000 | $26.00 | $130K | 116.9Kdirect | Apr 23, 2020 | Apr 24, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −4,200 | $25.05 | $105K | 853.0Kdirect | Apr 22, 2020 | Apr 22, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −5,800 | $25.04 | $145K | 857.2Kdirect | Apr 21, 2020 | Apr 22, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −5,900 | $24.70 | $146K | 863.0Kdirect | Apr 20, 2020 | Apr 22, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.6K | $24.07 | $616K | 868.9Kdirect | Apr 20, 2020 | Apr 22, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −18.5K | $23.39 | $433K | 894.5Kdirect | Apr 20, 2020 | Apr 22, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −5,000 | $24.00 | $120K | 116.9Kdirect | Apr 20, 2020 | Apr 22, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $18.31 | $458K | 913.0Kdirect | Apr 15, 2020 | Apr 17, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −7,065 | $18.35 | $130K | 938.0Kdirect | Apr 8, 2020 | Apr 9, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −16.4K | $18.25 | $300K | 945.1Kdirect | Apr 7, 2020 | Apr 9, 2020 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −50.0K | $17.26 | $863K | 126.5Kdirect | Apr 6, 2020 | Apr 8, 2020 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −13.8K | $16.57 | $229K | 161.7Kdirect | Apr 3, 2020 | Apr 3, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −1,500 | $18.06 | $27K | 961.5Kdirect | Mar 31, 2020 | Apr 2, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −4,318 | $15.37 | $66K | 116.9Kdirect | Mar 20, 2020 | Mar 20, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $19.60 | $980K | 325.1Kdirect | Mar 4, 2020 | Mar 6, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $19.20 | $960K | 375.1Kdirect | Mar 4, 2020 | Mar 6, 2020 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −653 | $18.41 | $12K | 8,521direct | Mar 3, 2020 | Mar 5, 2020 | Form 4 ↗ |
| FELDBAUM CARL BDirector | Sale | −37.3K | $18.85 | $704K | 9,174direct | Mar 3, 2020 | Mar 5, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −500 | $19.60 | $10K | 86.0Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −24.5K | $18.90 | $463K | 86.5Kdirect | Feb 26, 2020 | Feb 28, 2020 | Form 4 ↗ |
| Haley Patrick J.EVP, Commercial | Sale | −5,000 | $22.00 | $110K | 121.2Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $21.75 | $544K | 86.0Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −40.0K | $21.50 | $860K | 325.1Kdirect | Feb 19, 2020 | Feb 21, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −50.0K | $20.73 | $1.0M | 963.0Kdirect | Feb 18, 2020 | Feb 21, 2020 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −12.5K | $21.02 | $263K | 48.8Kdirect | Feb 14, 2020 | Feb 14, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $20.11 | $503K | 86.0Kdirect | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −21.0K | $20.02 | $420K | 1.0Mdirect | Feb 12, 2020 | Feb 12, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −4,000 | $20.14 | $81K | 1.0Mdirect | Feb 11, 2020 | Feb 12, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $18.37 | $919K | 325.1Kdirect | Feb 7, 2020 | Feb 7, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $17.87 | $447K | 86.0Kdirect | Jan 29, 2020 | Jan 31, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $19.41 | $485K | 86.0Kdirect | Jan 23, 2020 | Jan 24, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $19.75 | $494K | 1.0Mdirect | Jan 22, 2020 | Jan 24, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $20.33 | $508K | 86.0Kdirect | Jan 16, 2020 | Jan 17, 2020 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −61.7K | $20.01 | $1.2M | 82.5Kdirect | Jan 15, 2020 | Jan 17, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $20.39 | $510K | 1.1Mdirect | Jan 15, 2020 | Jan 17, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $18.85 | $471K | 86.0Kdirect | Jan 8, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −87.0K | $18.01 | $1.6M | 61.3Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $17.96 | $898K | 325.1Kdirect | Jan 7, 2020 | Jan 9, 2020 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −25.0K | $17.49 | $437K | 86.0Kdirect | Jan 2, 2020 | Jan 3, 2020 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $18.25 | $456K | 1.1Mdirect | Dec 27, 2019 | Dec 27, 2019 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $16.22 | $811K | 313.6Kdirect | Dec 3, 2019 | Dec 5, 2019 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −50.0K | $15.99 | $800K | 324.3Kdirect | Nov 4, 2019 | Nov 6, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −303 | $16.27 | $5K | 89.2Kdirect | Oct 10, 2019 | Oct 11, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −26.4K | $17.66 | $466K | 205.1Kdirect | Oct 2, 2019 | Oct 4, 2019 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −30.0K | $17.87 | $536K | 324.3Kdirect | Oct 1, 2019 | Oct 3, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −37.2K | $19.20 | $715K | 196.1Kdirect | Sep 18, 2019 | Sep 20, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $18.84 | $19K | 85.5Kdirect | Sep 10, 2019 | Sep 12, 2019 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −75.0K | $21.10 | $1.6M | 233.8Kdirect | Aug 16, 2019 | Aug 20, 2019 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −25.0K | $20.50 | $513K | 112.8Kdirect | Aug 16, 2019 | Aug 19, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −35.0K | $20.11 | $705K | 165.1Kdirect | Aug 14, 2019 | Aug 16, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $20.39 | $20K | 86.5Kdirect | Aug 12, 2019 | Aug 14, 2019 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −20.0K | $20.60 | $412K | 112.8Kdirect | Aug 9, 2019 | Aug 9, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −25.0K | $20.02 | $501K | 87.5Kdirect | Aug 6, 2019 | Aug 8, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −35.0K | $20.25 | $710K | 150.1Kdirect | Aug 2, 2019 | Aug 2, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −6,050 | $21.23 | $128K | 1.1Mdirect | Aug 1, 2019 | Aug 2, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −34.0K | $20.48 | $695K | 1.1Mdirect | Aug 1, 2019 | Aug 2, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −34.7K | $21.37 | $742K | 135.1Kdirect | Jul 17, 2019 | Jul 19, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $20.96 | $21K | 87.5Kdirect | Jul 10, 2019 | Jul 12, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −34.7K | $21.03 | $730K | 119.9Kdirect | Jul 3, 2019 | Jul 3, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −40.0K | $21.58 | $863K | 1.2Mdirect | Jul 1, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −100.0K | $20.67 | $2.1M | 117.2Kdirect | Jun 18, 2019 | Jun 19, 2019 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −17.4K | $20.76 | $361K | 117.2Kdirect | Jun 17, 2019 | Jun 19, 2019 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −100.0K | $20.49 | $2.0M | 117.2Kdirect | Jun 17, 2019 | Jun 19, 2019 | Form 4 ↗ |
| Lamb PeterEVP, Scientific Strategy & CSO | Sale | −27.6K | $20.03 | $553K | 117.2Kdirect | Jun 13, 2019 | Jun 14, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $20.23 | $20K | 88.5Kdirect | Jun 10, 2019 | Jun 12, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −15.0K | $20.00 | $300K | 1.2Mdirect | Jun 4, 2019 | Jun 5, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $19.61 | $490K | 1.2Mdirect | Jun 3, 2019 | Jun 5, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $19.58 | $20K | 89.5Kdirect | May 10, 2019 | May 10, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −42.0K | $20.15 | $846K | 90.0Kdirect | May 8, 2019 | May 10, 2019 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −50.0K | $20.36 | $1.0M | 368.3Kdirect | May 8, 2019 | May 10, 2019 | Form 4 ↗ |
| Senner Christopher J.EVP and CFO | Sale | −36.3K | $20.70 | $751K | 112.4Kdirect | May 3, 2019 | May 3, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −15.0K | $20.00 | $300K | 1.2Mdirect | May 2, 2019 | May 3, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −25.0K | $19.75 | $494K | 1.2Mdirect | May 1, 2019 | May 3, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −40.0K | $20.75 | $830K | 90.0Kdirect | Apr 24, 2019 | Apr 26, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −1,000 | $24.04 | $24K | 88.8Kdirect | Apr 10, 2019 | Apr 12, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −40.0K | $24.06 | $962K | 90.0Kdirect | Apr 10, 2019 | Apr 12, 2019 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −63.1K | $25.00 | $1.6M | 316.5Kdirect | Apr 3, 2019 | Apr 3, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −5,000 | $25.03 | $125K | 1.3Mdirect | Apr 3, 2019 | Apr 3, 2019 | Form 4 ↗ |
| WYSZOMIERSKI JACK LDirector | Sale | −7,822 | $23.97 | $187K | 120.2Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −40.0K | $24.02 | $961K | 1.3Mdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Hessekiel JeffreyEVP and General Counsel | Sale | −20.0K | $24.03 | $481K | 233.8Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −15.0K | $23.97 | $360K | 61.3Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| Garber Alan MDirector | Sale | −15.0K | $24.00 | $360K | 61.3Kdirect | Apr 1, 2019 | Apr 3, 2019 | Form 4 ↗ |
| POSTE GEORGEDirector | Sale | −3,860 | $23.89 | $92K | 102.5Kdirect | Mar 29, 2019 | Mar 29, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −40.0K | $23.39 | $936K | 90.0Kdirect | Mar 27, 2019 | Mar 29, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −2,700 | $23.47 | $63K | 89.8Kdirect | Mar 26, 2019 | Mar 27, 2019 | Form 4 ↗ |
| Schwab GiselaPres, Prod Dev & Med Aff & CMO | Sale | −100.0K | $23.14 | $2.3M | 316.5Kdirect | Mar 25, 2019 | Mar 27, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −5,000 | $25.00 | $125K | 1.3Mdirect | Mar 14, 2019 | Mar 15, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −2,000 | $25.00 | $50K | 89.8Kdirect | Mar 14, 2019 | Mar 15, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −28.4K | $24.80 | $704K | 90.0Kdirect | Mar 13, 2019 | Mar 15, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −11.6K | $24.24 | $282K | 118.4Kdirect | Mar 13, 2019 | Mar 15, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −959 | $23.13 | $22K | 89.8Kdirect | Mar 11, 2019 | Mar 13, 2019 | Form 4 ↗ |
| SCANGOS GEORGE ADirector | Sale | −40.0K | $22.66 | $906K | 1.3Mdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| MORRISSEY MICHAELPresident and CEO · Director | Sale | −40.0K | $22.69 | $908K | 90.0Kdirect | Feb 27, 2019 | Mar 1, 2019 | Form 4 ↗ |
| COHEN CHARLESDirector | Sale | −5,271 | $22.18 | $117K | 21.0Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| Haley Patrick J.Sr. Vice President, Commercial | Sale | −4,272 | $22.27 | $95K | 90.7Kdirect | Feb 25, 2019 | Feb 27, 2019 | Form 4 ↗ |
| MARCHESI VINCENT TDirector | Sale | −41.3K | $21.50 | $887K | 133.8Kdirect | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| PAPADOPOULOS STELIOSDirector | Sale | −26.3K | $21.25 | $558K | 1.0Mdirect | Feb 21, 2019 | Feb 22, 2019 | Form 4 ↗ |
| WILLSEY LANCEDirector | Sale | −26.3K | $21.11 | $554K | 418.3Kdirect | Feb 20, 2019 | Feb 22, 2019 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →